Friday, 26 January 2018

Apotex CEO Jeremy Desai resigns

(Reuters) - Canadian generic drug maker Apotex Inc's Chief Executive Jeremy Desai has resigned, effective immediately, the company said on Friday.


No comments:

Post a Comment